Quantcast

Jump to: site navigation, content.

Monday, May 5, 2008

Dallas-based Access Pharmaceuticals featured in investment book

Email Print Tell us your story Comment

Access Pharmaceuticals announced today that renowned business columnist and author Gene Marcial of BusinessWeek has highlighted Access Pharmaceuticals in his recently released investing book titled "7 Commandments of Stock Investing." In a section pertaining to his sixth commandment of "not fearing the unknown," Mr. Marcial includes Access Pharmaceuticals as one of three "unrecognized attractive biotechs" that are not widely followed by Wall Street but "whose prospects look tantalizing because of their huge potential value." Included in the analysis is commentary on Access' ProLindac, its proprietary second-generation DACH platinum drug that is being developed to target the markets currently being served by Sanofi-Aventis' Eloxatin, and on MuGard, Access' FDA-approved treatment for oral mucositis. Gene Marcial has been BusinessWeek's "Inside Wall Street" columnist for the past 26 years, and is a former columnist at the Wall Street Journal.

Source: Access Pharmaceuticals


Related stories


See more stories in:

Post a comment

(Requires free PegasusNews.com account.)


Password: (Forgotten your password?)


Today

Akira Sato Jazz trumpeter Akira Sato, by way of Tokyo, Japan and Vancouver, Canada, is an SMU faculty member and director of The Meadow Jazz Orchestra at SMU. He is also an adjunct faculty member at UNT where he teaches jazz arranging. Sato is also heading into the studio soon with other area musicians and playing at the Scat Jazz Lounge tonight. With all that he's up to, the least you could do is order a Scotch on the rocks and chill to some tunes. (Photo by flickr user arteunporro. More info

Latest comments

See more recent comments

Latest reviews

See more recent reviews